Inactive Instrument

Calendar Nanoantibiotics Inc Other OTC

Equities

US63009U1025

End-of-day quote Other OTC Other stock markets
- ^USD	-

29/04	BioVie Gets up to $13.1 Million From US Defense Department to Evaluate Bezisterim for Long COVID	MT
29/04	BioVie Awards up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim for the Treatment of Long COVID	CI

Chart calendar Nanoantibiotics Inc

5dc8dfaa282cc0168735dad0abc.WqLemdXAggZyIySm8uv3Avbn1v_C2BrspYMRtGhMDus.McyvrYCR2D85awnxvp7EcM-AurOvln6v_Ot68AYjd5027I3B5q-ySjhQbQ~262c48d2e400b71b024686bc6a824b44

Upcoming events on Nanoantibiotics Inc

13/05/2024

Q1 2025 Earnings Release (Projected)

Past events on Nanoantibiotics Inc

10/05/2024	Q3 2024 Earnings Release (Projected)
10/04/2024	RedChip Investor Group Call
09/03/2024 08:40 pm	Alzheimer and Parkinson Diseases International Conference
08/03/2024 08:20 pm	Alzheimer and Parkinson Diseases International Conference
14/02/2024 11:10 pm	Oppenheimer Healthcare Life Sciences Conference
29/11/2023 07:00 pm	NE3107 Phase 3 Trial Results Call
13/11/2023 11:30 pm	American Association for the Study of Liver Diseases Conference
08/11/2023 11:30 pm	Annual General Meeting
01/11/2023 05:30 pm	Business Update Call
25/10/2023 10:00 pm	Clinical Trials on Alzheimer Disease Conference
26/09/2023 08:00 pm	Cantor Global Healthcare Conference
11/09/2023	American Neurological Association meeting
08/09/2023 12:00 am	Investor Meeting - Key Opinion Leader
16/07/2023 12:15 pm	Alzheimer Associate International Conference
25/06/2023 12:00 am	American Diabetes Association Scientific Session - Poster: #1520
12/05/2023	Q3 2023 Earnings Release
25/04/2023 09:15 pm	American Academy of Neurology Meeting - Kaya Jordan
25/04/2023 05:30 pm	American Academy of Neurology Meeting - Joseph Palumbo
23/04/2023 05:30 pm	American Academy of Neurology Meeting - Nilab Osman
01/04/2023 07:30 pm	Alzheimer & Parkinson Disease International Conference

Annual results

Fiscal Period	Juni	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,00	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EBITDA	Released Forecast Spread	0,00	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	-2,69	-138 -43,5 -217.37%	-27,3 -26,6 -2.35%	-45,1 -47,7 5.58%	-48,6
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00	-130 -35,8 -263.82%	-26,1 -28,3 7.7%	-50,3 -55,4 9.27%	-49,4
Net income Million USD	Released Forecast Spread	0,00	-184 -89,4 -105.65%	-26,1 -27,4 4.87%	-50,3 -55,4 9.27%	-49,4
EPS USD	Released Forecast Spread	-6,85	-14,8 -7,18 -106.41%	-1,06 -1,12 5.57%	-1,55 -1,76 11.93%	-1,02
Announcement Date		06/08/20	30/08/21	27/09/22	16/08/23	-

Quarterly results

Fiscal Period	Juni	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00
EBIT Million USD	Released Forecast Spread	-6,67 -10,3 35.29%	-5,75 -7,87 26.98%	-9,29 -9,56 2.84%	-8,83 -6,45 -37.07%	-11,5 -9,02 -27.48%	-13,8 -9,90 -39.21%	-11,0 -13,6 19.52%		-8,78 -11,4 22.91%	-12,6	-13,5
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-5,41 -10,9 50.33%	-7,04 -8,18 13.91%	-8,09 -10,3 21.19%	-10,4 -6,84 -52.32%	-15,7 -9,78 -60.36%	-15,0 -11,7 -28.3%	-9,11 -14,2 36.03%		-8,40 -11,9 29.42%	-12,9	-13,7
Net income Million USD	Released Forecast Spread	-5,41 -10,9 50.33%	-7,04 -8,18 13.91%	-8,09 -9,42 14.15%	-10,4 -6,84 -52.32%	-15,7 -9,78 -60.36%	-15,0 -11,7 -28.3%	-9,11 -14,2 36.03%		-8,40 -11,9 29.42%	-12,9	-13,7
EPS USD	Released Forecast Spread	-0,22 -0,41 46.34%	-0,28 -0,28 0%	-0,33 -0,37 11.41%	-0,38 -0,29 -33.33%	-0,50 -0,25 -98.02%	-0,43 -0,36 -21.13%	-0,23 -0,40 42.5%	-0,29 -0,31 6.45%	-0,22 -0,28 20%	-0,25	-0,26
Announcement Date		08/02/22	11/05/22	27/09/22	04/11/22	10/02/23	12/05/23	16/08/23	08/11/23	13/02/24	-	-

Upcoming sector events for Nanoantibiotics Inc

13/05/2024	PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release
13/05/2024	ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release
13/05/2024	CEREVEL THERAPEUTICS HOLDINGS, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024	LEGEND BIOTECH CORPORATION: Q1 2024 Earnings Release
13/05/2024	PEPTRON, INC.: Q1 2024 Earnings Release (Projected)
14/05/2024	IMMATICS N.V.: Q1 2024 Earnings Release (Projected)
14/05/2024	ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024	PEPTIDREAM INC.: Q1 2024 Earnings Release
14/05/2024	NYKODE THERAPEUTICS: Q1 2024 Earnings Release
14/05/2024	ABL BIO INC.: Q1 2024 Earnings Release (Projected)

More events

Past sector events for Nanoantibiotics Inc

11/05/2024 01:32 am	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release
10/05/2024 05:56 pm	ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release
10/05/2024 05:30 pm	PRIME MEDICINE, INC.: Q1 2024 Earnings Release
10/05/2024 04:30 pm	AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release
10/05/2024 05:35 am	SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release
10/05/2024	TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected)
10/05/2024 01:45 am	ANAPTYSBIO, INC.: Q1 2024 Earnings Release
10/05/2024 01:40 am	ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release
10/05/2024 01:39 am	XENCOR, INC.: Q1 2024 Earnings Release
10/05/2024 01:35 am	STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release